Operation for Angina Pectoris
Surgeons have devised many operations to provide a flow of arterial blood to ischaemic myocardium, but the only one to have stood the test of time is the most improbable of them all-the implantation of an internal mammary artery, originally performed by A. Vineberg in 1950.1 An internal mammary artery, dissected from the chest wall and implanted with bleeding side holes into the wall of the left ventricle, surprisingly neither undergoes thrombosis nor causes a large intramural haematoma but establishes vascular connexions with the coronary circulation. These connexions reach some size by about six weeks and their maximum at -about six months.2 The operation never became popular, because of the difficulties of correlating relief of angina with any specific surgical intervention, but the development of coronary arteriography by Mason Sones at the Cleveland Clinic' has revived interest in it by showing in living patients that an implanted internal mammary artery does indeed restore the vascular function of coronary arteries distal to an arteriosclerotic occlusion. Angiographic evidence of perfusion of a blocked coronary artery is not necessarily the same as oxygenation of the myocardium, but R. Gorlin' has shown by special techniques that the myocardium is in fact perfused from the internal mammary artery and that its metabolism usually reverts from an anaerobic to an aerobic pattern.
The investigatory tests, the indications for operation, its technical details, and its results have now therefore become of real clinical importance. Donald Effler and his colleagues, for instance, have already performed 2,000 Vineberg operations at the Cleveland Clinic.4 Coronary arteriography is first undertaken to determine whether the patient's angina is due to myocardial ischaemia, and it delineates the extent of the coronary arterial occlusive disease. Left ventricular angiography provides evidence of the contractility of the myocardium.' 4 5
The indications for recommending the Vineberg operation vary from one cardiac centre to another, but the chief one is severe angina in a patient who has one or more coronary arteries narrowed to at least 25 % of their normal lumen, particularly if he is young or has a strong family history of myocardial infarction. Cardiac failure is the main contraindication, because it is not improved by internal mammary implantation. Failure is judged by cardiac enlargement, a markedly raised end-diastolic pressure in the left ventricle, or evidence of poor myocardial contractility as seen by angiography. Other contraindications are status anginosus (unprovoked angina), extensive arteriosclerosis elsewhere, and left ventricular aneurysm, but a previous myocardial infarct does not preclude operation, because there must be live muscle to produce angina.
Results of the Vineberg operation may be assessed by operative mortality, relief of angina, and increased longevity. By careful selection of patients and implantation of one or both internal mammary arteries into demonstrably ischaemic but still contracting parts of the left ventricle the operative mortality has been reduced to approximately 5%, and the graft remains patent in 80% of the survivors. Clinical improvement is closely related to patency of the graft, and complete or partial relief of angina is also achieved in some 80% of the survivors.2 4-6 Increased longevity or prevention of subsequent infarction cannot yet be claimed for the operation with any certainty, though it is becoming apparent with increasing length of follow-up that patients with a patent internal mammary implant seem to have a better chance of survival than those with an occluded implant or than comparable patients who have not had an operation at all.2
The Vineberg operation of internal mammary artery implantation is no longer an experimental procedure but is becoming an accepted surgical operation with well-defined indications, contraindications, operative technique, and results. There is little doubt that it will soon be part of the surgical armamentarium of every cardiac centre.
